We sit down with you and build your perfect lead list. Book a call with founders.

ProtonDx Analysis: $11M Raised

What is ProtonDx?

Portable molecular testing with LAMP technology
Location
London, United Kingdom
Employees
11-50
Founded
2020

Product Features & Capabilities

  • Dragonfly device for human pathogen detection
  • SmartLid for rapid nucleic acid extraction
  • TurboBeads for enhanced sample processing
  • Solvent-free wash buffer for clean sample preparation
  • LyoLAMP for portable molecular testing

Use Cases

Detect respiratory viruses in point-of-care settings; Perform pathogen screening in animal health clinics; Enable rapid diagnostics in life sciences research labs; Extract nucleic acids from clinical samples in under 10 minutes; Support multi-pathogen testing in field environments

Other Considerations

Spun out of Imperial College London in 2020; Awarded IEEE CASS COVID-19 Entrepreneur’s Award; Awarded IET Mike Sergeant Achievement Medal; Recognized with Rosetrees Trust Interdisciplinary Prize; Recognized with Wellcome Trust Innovator Award; Received two Imperial Techcelerate Awards; Awarded MedTech SuperConnector Award; Multiple IEEE awards

Find more companies like ProtonDx

VC-backed University Spinouts

See something that needs updating? Suggest edits to this profile.

Financial Overview

$11MTotal Raised
Series A
Want to research more data points on ProtonDx?
Start with Extruct

Platform Links